Navigation Links
HealthSouth Reports Strong Results for Third Quarter 2009 and Increases 2009 Guidance
Date:11/3/2009

==== Diluted 96.4 ====

HealthSouth Corporation and Subsidiaries

Supplemental Non-GAAP Disclosures

Notes to Reconciliations

(1) Adjusted income from continuing operations and Adjusted Consolidated EBITDA are non-GAAP financial measures. The Company's leverage ratio (consolidated total debt to Adjusted Consolidated EBITDA for the trailing four quarters) is likewise a non-GAAP financial measure. Management and some members of the investment community utilize adjusted income from continuing operations as a financial measure and Adjusted Consolidated EBITDA and the leverage ratio as liquidity measures on an ongoing basis. These measures are not recognized in accordance with GAAP and should not be viewed as an alternative to GAAP measures of performance or liquidity. In evaluating these adjusted measures, the reader should be aware that in the future HealthSouth may incur expenses similar to the adjustments set forth above.

(2) Per share amounts for each period presented are based on basic weighted average common shares outstanding for all amounts except adjusted income from continuing operations per diluted share, which is based on diluted weighted average common shares outstanding. The diluted share counts contain approximately 13.1 million shares related to the potential dilution of the Company's convertible perpetual preferred stock. The increase in the Company's basic and diluted weighted average common shares outstanding for the nine months ended September 30, 2009 compared to the same period of 2008 was primarily the result of its equity offering of 8.8 million shares that was completed on June 27, 2008.

(3) In the first quarter of 2008, the Company accelerated the depreciation of its corporate campus so that the net book va
'/>"/>

SOURCE HealthSouth Corporation
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine news :

1. HealthSouth Announces Date of 2009 Third Quarter Earnings Conference Call
2. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
3. Wellmont, HealthSouth Form Joint Venture to Open a New Rehabilitation Hospital in Southwest Virginia
4. ATSU Arizona Health & Technology Park Partner HealthSouth Holds Grand Opening
5. HealthSouth Comments on Civil Litigation
6. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
7. HealthSouth Announces Date of 2009 Second Quarter Earnings Conference Call
8. Court Rules in Favor of HealthSouth in Litigation Involving General Medicine, P.C.
9. HealthSouth to Present at 34th Annual Deutsche Bank Health Care Conference
10. HealthSouth Reports Strong EPS Results for First Quarter Ended March 31, 2009
11. HealthSouth to Present at Bairds 2009 Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... 17 On the heels of unveiling the ... the 2010 race, LA Marathon officials today announced a ... raising funds for causes ranging from cancer research to ... expanded charity program is in line with the vision ... has the potential to be a huge philanthropic force ...
(Date:12/17/2009)... Dec. 17 /PRNewswire-Asia/ -- China,s leading high-tech,healthcare group, ... Stock Code: 801) is pleased to announce today ... period under review, the Group,s two,associate companies made ... and NASDAQ;,its key businesses have been strengthened, with ... management operations. , Mr. ...
(Date:12/17/2009)... Brandeis University selected Jay and Maureen Neitz, the husband-and-wife ... of gene therapy to treat vision disorders, as the ... Vision Sciences. , The award is funded by a ... from Brandeis graduates Jay Pepose ,75 and Susan K. ... research fellowships in vision science. , The Neitzes, both ...
(Date:12/17/2009)... use in era of sexually explicit messaging, experts say ... and preteens spend hours sending text messages from their ... messages -- sexually explicit material, giving the messaging the ... University of Michigan researchers report. , In fact, a ... are worried about the time their children spend sending ...
(Date:12/17/2009)... firm’s Interim Leadership division as senior vice president. A seasoned executive ... assume her duties at B. E. Smith today. , ... ... Smith recently hired Deirdre Byrne to lead the firm’s Interim ... 20 years of experience in healthcare consulting, Byrne will assume her ...
Breaking Medicine News(10 mins):Health News:LA Marathon Unveils Expanded Charity Program; Sixty Official Charities to Take Part in 2010 Race 2Health News:LA Marathon Unveils Expanded Charity Program; Sixty Official Charities to Take Part in 2010 Race 3Health News:LA Marathon Unveils Expanded Charity Program; Sixty Official Charities to Take Part in 2010 Race 4Health News:Golden Meditech Announces Interim Results of FY2009/10 2Health News:Golden Meditech Announces Interim Results of FY2009/10 3Health News:Vision researchers Jay and Maureen Neitz to receive first Pepose Award from Brandeis 2Health News:'Sexting' by Kids Begets Fretting by Parents 2Health News:Deirdre Byrne Joins B. E. Smith as Senior Vice President, Interim Leadership Services 2Health News:Deirdre Byrne Joins B. E. Smith as Senior Vice President, Interim Leadership Services 3
... According to the latest on breast-feeding, there is no hard and ... Most young mothers would be more than glad to ... feeding, can prove too painful for motherly feelings to override. ... a horrendous time trying to breastfeed when her daughter Deborah was ...
... United States the gays prefer to find out whether their ... than use protection to prevent catching the disease. The ... transmitting the virus, which is on the rise. ... with HIV virus and they continue to have unprotected sex. ...
... the functioning of maternity units in UK is an eye-opener ... affair in the hospitals. In a sting operation conducted by ... some alarming practices. ,Some of the maternity units ... most midwives were overburdened with work. The midwife in charge ...
... United Arab Emirates (UAE) said the government is working to ... country's prevention programme of genetic disorders. ,"We ... child's health. But the choice to have the abortion will ... to be within the religious and social environment," Ali Shakar ...
... National AIDS Control Organisation (NACO) has launched an educational ... is being implemented by all the States and Union ... is aimed at the following learning outcomes: (i) to ... process of growing up during adolescence, HIV/AIDS and drug ...
... Health Minister P.K. Sreemathi and seven others for culpable homicide ... newborns in a hospital due to infection. ... judgement on a complaint by a person regarding infant deaths ... ,The deaths were due to infection the infants contracted in ...
Other Medicine News:Health News:New Research Promises To Take The Pain Off Breast Feeding 2Health News:New Research Promises To Take The Pain Off Breast Feeding 3Health News:Unprotected Sex Among the Gays on the Rise 2Health News:United Kingdom: Maternity Units Exposed! Leaves Much to Be Desired 2Health News:Kerala Health Minister Charged for Infant Deaths in a Hospital 2
(Date:12/16/2009)... Dec. 16 A new ... manage the clinical review of specialty pharmaceuticals has ... of drugs reviewed while reducing costs. ,, AIM, ... company with health plan clients representing over 35 ... Inc. (NYSE: WLP ), adapted the ...
(Date:12/16/2009)... REYKJAVIK, Iceland, December 16 Scientists at,deCODE ... journal Nature the,discovery of a version of a ... genome (SNP) with a major impact on susceptibility ... T2D variant is not only large, but unusual:,if ... variant increases risk of,T2D by more than 30% ...
(Date:12/16/2009)... NEW YORK, December 16 ... the publication of GFT505 (80 mg/day),data ... 50 internationally,recognized expert scientists and clinicians ... the continuing role of generic lipid-modifying,treatments, ... which is commonly observed in patients ...
Breaking Medicine Technology:American Imaging Management's New Specialty Drug Program Delivers Immediate Results 2American Imaging Management's New Specialty Drug Program Delivers Immediate Results 3American Imaging Management's New Specialty Drug Program Delivers Immediate Results 4deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 2deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 3deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 4International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia 2International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia 3A new bent on fusion 9637 1A new bent on fusion 9637 2Princeton team learns why some drugs pack such a punch 9635 1Princeton team learns why some drugs pack such a punch 9635 2Princeton team learns why some drugs pack such a punch 9635 3ESCO Announces Major Contract Award for Its Thermoforming Business 54966 1ESCO Announces Major Contract Award for Its Thermoforming Business 54966 2
... by the European Commission, ATRIPLA Would Represent the, First and Only Once-Daily ... ... PRINCETON, N.J., FOSTER CITY, Calif. and WHITEHOUSE STATION, N.J., Oct.,18 Bristol-Myers ... and Merck & Co., Inc. (NYSE: MRK ),announced today that the ...
... Society for Reproductive Medicine meeting could significantly improve ability to identify embryos ... patients, AFA supports efforts to bring advanced screening technology to patients as,quickly as ... ... procedures, NEW YORK, Oct. 18 According to results ...
Other Medicine Technology:European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 2European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 3European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 4European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 5European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 6European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 7European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 8European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 9European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) 10American Fertility Association Calls for Expanded Research to Advance New Technology to Screen Embryos for Genetic Abnormalities 2American Fertility Association Calls for Expanded Research to Advance New Technology to Screen Embryos for Genetic Abnormalities 3
... 2000 Digoxin Assay is a ... use in the quantitative analysis ... or plasma. Kits are packaged ... Roche COBAS MIRA, COBAS MIRA ...
The Emit 2000 Digoxin Assay is a homogeneous enzyme immunoassay for use in the quantitative analysis of digoxin in human serum or plasma. Kits are conveniently packaged in Olympus Reagent Cartridges ...
Liquichek Rheumatoid Factor Control is a liquid trilevel control designed to monitor rheumatoid factor testing procedures, including nephelometric and latex agglutination methods....
... The Newmarket Laboratories RPR kits use ... of lipid antigens, which will combine ... or plasma. The particles are suspended ... eliminate non - specific reactions. Positive ...
Medicine Products: